The Division of Cancer Prevention and Population Sciences was moved to the new Cancer Prevention Building in January 2005. With more than 27,295 square feet and approximately 2,000 square feet in lab space, the Division houses five departments, one care center, two research centers, and one recently established institute, the Duncan Family Institute for Cancer Prevention and Risk Assessment. More than 500 faculty, researchers, trainees and staff are affiliated with the Division and contribute to the continued growth of its cancer prevention and population sciences research and its clinical cancer prevention services.
Duncan Family Institute Milestones
7 December 2010
Xifeng Wu, MD, PhD, has been named Director of the newly created Center for Translational and Public Health Genomics. The mission of this Center is to bridge the gap between epidemiologic discoveries and their translation into clinical and public health applications to benefit cancer patients, individuals at elevated risk for cancer and the general population. With the rapid development of new high-throughput biomedical technologies that generate genomic information at an unprecedented pace, we have the opportunity to make major breakthroughs in the pursuit of personalized risk prediction, prevention and therapy.
4 December 2010
The third round of Seed Funding Research Program awards were given out:
- Michelle Hildebrandt, PhD "Germline genetic variants in the Wnt/beta-catenin stem cell pathway as predictors of colorectal cancer risk"
- Yanhong Liu, PhD "Glioma susceptibility in African American and Hispanic Populations"
16 September 2010
Duncan Family Institute Executive Committee is pleased to fund the proposal to establish a Clinical Cancer Prevention Research Core. The proposed Clinical Cancer Prevention Research Core (CCP Research Core) will be a shared resource for department faculty providing consistent support to:
- Recruit, enroll and manage clinical trial participants
- Collect and enter long term clinical outcome data for predictive and prognostic biomarkers testing
- Develop and maintain departmental research database(s)
- Perform quality assurance monitoring along with study specific data management.
The overall goal of the Clinical Cancer Prevention Research Core will be to further the development, implementation and conduct of clinical prevention.
8 September 2010
The second round of Seed Funding Research Program awards were given out:
- Ashraful Hoque, MD, PhD "Pilot Biomarker Study of Trace Metals and Prostate Cancer Risk"
- Bo Peng, PhD "Cost-effectiveness studies of novel cancer prevention strategies"
9 August 2010
The Duncan Family Institute Executive Committee in collaboration with the Cancer Prevention Research Training Program leadership offers the second Mentored Junior Faculty Fellowship to Larkin Strong, PhD, MPH. The focus of Dr. Strong's research is "An ecological approach to cancer prevention: Reducing disparities in physical activity through research and action".
3 March 2010
The Duncan Family Institute Executive Committee in collaboration with the Cancer Prevention Research Training Program leadership offers the Duncan Family Institute Mentored Junior Faculty Fellowship to Francesco Versace, PhD. The focus of Dr. Versace's research is "Putting smoking addiction in the affective context: Event-related potentials to emotional and neutral stimuli during a smoking cessation intervention”.
7 February, 2010
The first round of Seed Funding Research Program awards were given out:
- Imad Shureiqi, MD, MS "Role of PPAR-delta Overexpression in Colonic Tumorigenesis"
- Chongjuan Wei, PhD "Role of PPAR-delta Overexpression in Colonic Tumorigenesis"
- Xiaochun Xu, MD, MD, PhD "Preclinical Chemoprevention of Esophageal Adenocarcinoma"
- Yuanqing Ye, PhD "Predicting the Link of Developing Lung Cancer: A Multigenic Statistical Approach to MicroRNA"
20 November, 2009
The Duncan Family Institute Executive Committee announced a second call for applications being accepted for the Duncan Family Institute Mentored Junior Faculty Fellowship in Cancer Prevention Research to support a faculty member at the rank of instructor for up to two years. The Phase 1-Initial Application deadline is February 16, 2010 for an appointment anticipated to begin September 2010. This call for applications is open to both internal and external applicants.
19 November, 2009
The Duncan Family Institute for Cancer Prevention and Risk Assessment announced an opportunity to apply for funding to support transdisciplinary cancer prevention research in one of eight focus areas as follows:
- Tobacco Prevention / Cessation / Nicotine Dependence
- Energy Balance
- Prevention and / or Screening
- Multiple Risk Factor Interventions
- Integrative Preventive Oncology
- Health Disparities
- Youth Risk Factors
- Prevention Research in Cancer Survivors
The proposed research program is expected to be comprised of multiple interrelated projects supporting a central research focus and core resources necessary to support the projects. The individual projects should be interrelated such that the research efforts are synergistic thereby allowing progress to occur at a greater rate and result in a greater contribution to program goals than if each project were pursued separately. Investigators must demonstrate to reviewers that their research program is likely to be fundable once the investigators establish the research program and develop preliminary data. Applicants awarded funding through this program are expected to subsequently apply for support from other non-MD Anderson sources. Awards are for up to $300,000 per year for 2 years; $600,000 total. The letter of intent deadline is 5PM January 19, 2010. The Duncan Family Institute anticipates it will make 1 award in this cycle.
6 October, 2009
The Duncan Family Institute for Cancer Prevention and Risk Assessment announced an opportunity to apply for funding to support Cancer Prevention and Risk Assessment research via a Seed Funding Research Program.The major purpose of this Seed Grant Program is to encourage research in the broad topic of cancer prevention and risk assessment in order to allow faculty to obtain preliminary data to improve competitiveness of cancer prevention and risk assessment research grant proposals submitted to external agencies. Individual awards are up to $50,000 per year for 2 years; $100,000 total. The application deadline was November 16, 2009. The Duncan Family Institute anticipates to award 4 grants in this cycle.
16 September, 2009
The Duncan Family Institute Executive Committee announced that applications were being accepted for the Duncan Family Institute Mentored Junior Faculty Fellowship in Cancer Prevention Research which will support a faculty member at the rank of instructor for up to two years. The Phase 1-Initial Application deadline was October 9, 2009 for an appointment beginning April 2010, and was limited to applicants internal to MD Anderson.
9 April, 2009
Duncan Family Institute faculty leaders present the first annual report to the Duncans. This was followed by a tour of the Behavioral Research and Treatment Center and the Cancer Prevention Center.
19 February, 2009
The Scientific Executive Committee is established to provide oversight of the research and use of the Duncan Family Institute's funds and ensure the excellence of the Institute's research programs.
24 January, 2009
The Duncan Family Institute for Cancer Prevention and Risk Assessment signs are installed on the Cancer Prevention Building.
1 November, 2008
Jenny Tektiridis joins MD Anderson Cancer Center's Division of Cancer Prevention and Population Sciences as executive director of research planning and development.
15 May, 2008
Announced during a news conference here on May 15, the Duncan Family's gift — the second largest in our institution’s history — will be used to support the newly established Duncan Family Institute for Cancer Prevention and Risk Assessment.
8 March, 2008
Duncan Family Foundation awards MD Anderson's Cancer Center with a $35 million gift for cancer prevention research.
Cancer Prevention and Population Sciences Faculty in the News
- Same cancer, different time zone Paul Scheet, Ph.D.
- End Tobacco: It will take a village to tackle tobacco Ernest Hawk, M.D., M.P.H. and Lewis Foxhall, M.D.
- High-tech 3D mammogram probably saved this woman's life Therese Bevers, M.D.
- Powerful tool combs family genomes to find shared variations causing disease Chad Huff, Ph.D.